Caribou Biosciences
CRBU

Caribou Biosciences (CRBU) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
B of A SecuritiesMaintainedBuy$5.00 from $6.00Aug 14, 2026
HC Wainwright & Co.MaintainedBuy$11.00 from $9.00May 11, 2026
HC Wainwright & Co.MaintainedBuy$9.00Apr 7, 2026
Evercore ISI GroupMaintainedOutperform$13.00 from $11.00Mar 9, 2026
Clear StreetInitiated CoverageBuy$13.00Feb 2, 2026
HC Wainwright & Co.MaintainedBuy$9.00 from $3.00Nov 5, 2025
CitigroupMaintainedBuy$8.00 from $5.00Nov 3, 2025
HC Wainwright & Co.MaintainedBuy$3.00 from $9.00Apr 28, 2025
HC Wainwright & Co.MaintainedBuy$9.00Mar 19, 2025
B of A SecuritiesMaintainedBuy$11.00 from $13.00Jan 7, 2025
CitigroupMaintainedBuy$6.00 from $30.00Nov 26, 2024
HC Wainwright & Co.MaintainedBuy$9.00Nov 15, 2024
HC Wainwright & Co.MaintainedBuy$9.00Sep 3, 2024
HC Wainwright & Co.MaintainedBuy$9.00Aug 14, 2024
HC Wainwright & Co.MaintainedBuy$9.00Jul 17, 2024
HC Wainwright & Co.MaintainedBuy$9.00 from $24.00Jun 4, 2024
Truist SecuritiesMaintainedBuy$19.00May 16, 2024
HC Wainwright & Co.MaintainedBuy$24.00May 13, 2024
HC Wainwright & Co.MaintainedBuy$24.00 from $23.00Mar 19, 2024
RBC CapitalMaintainedOutperform$19.00Mar 12, 2024

Frequently asked questions

  • What is the latest analyst rating on CRBU?

    On Aug 14, 2026, B of A Securities maintained Caribou Biosciences at Buy with a price target of $5.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.